Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis

Environmental factors, mucosal permeability and defective immunoregulation drive overactive immunity to a subset of resident intestinal bacteria that mediate multiple inflammatory conditions. GUT-103 and GUT-108, live biotherapeutic products rationally designed to complement missing or underrepresen...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Lelie, Daniel, Oka, Akihiko, Taghavi, Safiyh, Umeno, Junji, Fan, Ting-Jia, Merrell, Katherine E., Watson, Sarah D., Ouellette, Lisa, Liu, Bo, Awoniyi, Muyiwa, Lai, Yunjia, Chi, Liang, Lu, Kun, Henry, Christopher S., Sartor, R. Balfour
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163890/
https://www.ncbi.nlm.nih.gov/pubmed/34050144
http://dx.doi.org/10.1038/s41467-021-23460-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163890/
https://www.ncbi.nlm.nih.gov/pubmed/34050144
http://dx.doi.org/10.1038/s41467-021-23460-x

Ejemplares similares